New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular Docking, Lipinski’s Rule and ADMET Analysis
Year: 2023
Type: article
Source: Coronaviruses
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
Funder: Buraydah Private Colleges
Award: G2187543862
OpenAlex ID: W4388698002
